Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06710366Completed

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

Role: collaborator

NCT02781363Not ApplicableWithdrawn

Can the Thoracic Replace the Conventional Radiography for the Diagnosis of Acute Pneumonia in Children?

Role: lead

NCT01393769Phase 2Terminated

Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage

Role: collaborator

NCT02752503Not ApplicableUnknown

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

Role: collaborator

All 4 trials loaded